Weaver C. Barksdale & Associates’s Maxim Integrated Products MXIM Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio MXIM Stock Details MXIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.63M	Sell	31,212 -439	-1%	-$22.8K	1.72%	16
2017 Q3	$1.51M	Hold	31,651	–	–	1.68%	19
2017 Q2	$1.42M	Buy	31,651 +240	+0.8%	+$11K	1.66%	23
2017 Q1	$1.41M	Buy	31,411 +6,825	+28%	+$299K	1.66%	26
2016 Q4	$948K	Sell	24,586 -110	-0.4%	-$4.32K	1.53%	32
2016 Q3	$986K	Buy	24,696 +502	+2%	+$19.8K	1.66%	15
2016 Q2	$863K	Buy	+24,194	New	+$887K	1.5%	33

Other funds holding MXIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Weaver C. Barksdale & Associates's MXIM Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Maxim Integrated Products (MXIM) stake by 1.4% in Q4 2017, selling an estimated $22.8K and leaving 31,212 shares worth $1.63M. The position accounts for 1.72% of the portfolio, ranked #16.

Weaver C. Barksdale & Associates first reported a position in MXIM in Q2 2016 and has held it in 7 quarters since. 494 funds tracked by Wall St. Rank hold MXIM as of Q4 2017.

Weaver C. Barksdale & Associates held 31,212 shares of Maxim Integrated Products worth $1.63M as of Q4 2017.
Weaver C. Barksdale & Associates sold 439 Maxim Integrated Products shares in Q4 2017, an estimated $22.8K.
Maxim Integrated Products made up 1.72% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #16 holding.
Weaver C. Barksdale & Associates first reported a position in Maxim Integrated Products in Q2 2016 and has held it in 7 quarters since.
494 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.